symbol-NAM

NAM NAMWIWAT MEDICAL CORPORATION PUBLIC COMPANY LIMITED

NAM
NAMWIWAT MEDICAL CORPORATION PUBLIC COMPANY LIMITED
3.80
+0.14 (+3.83%)
High3.80
Low3.66
Total Vol7,500
Total Val(K)28.00
Description
Manufacturing, importing and distributing of medical devices for sterilizing medical equipment including medical consumables thereof as well as providing any or all related services

Overview


  • SymbolNAM
  • Market Cap (M.Bath)2,562.00
  • IPO Date31 Oct 2023
  • IPO Price7.70 @Par Value 0.50 Baht
  • CEOGEN. WINAI PHATTIYAKUL
  • Employees-
  • IndustryCONSUMP
  • SectorPERSON
  • Index-
  • SET ESG Ratings-

สรุปภาพรวมตลาด

NAMWIWAT MEDICAL CORPORATION PUBLIC COMPANY LIMITED
Websitewww.namwiwat.com
Address999/3-5 Moo 9 Pracha Uthit- Khu Sang Road, Naiklongplakod Sub-district, Phrasamutjedi District Samut Prakarn 10290
Telephone0-2461-7287-90
Fax0-2461-7291

Detail of Security

MarketSET
First Trade Date31 Oct 2023
IndustryCONSUMP
SectorPERSON
Foreign Limit (%)49.00 (Date 9 Apr 2026)
Foreign Ownership Limit Remaining (shares)338,921,600
Free Float (%)17.92
Par Value0.50
ISIN Number
Local : THB663010007
Foreign : THB663010015
NVDR : THB663010R15
Dividend PolicyThe Company has a dividend policy by taking into account for consideration the ability to pay dividends from the retained earnings based on the separate financial statements and the Company will also consider the amount of each dividend payment from the operating results in the consolidated financial statements where by the Company will consider to pay dividends at a rate of not less than 40% of net profits based on the Company`s consolidated financial statements, after deducting corporate income tax. However, the Company may consider paying dividends at a rate different from such policy rate depending on the operating results, financial position, financial liquidity and the fund necessity in managing and expanding the Company`s business including economic conditions. In addition, such dividend payment will not exceed the retained earnings shown in the Company`s separate financial statements and be made in accordance with the relevant laws. In this regard, the annual dividend payment of the Company is subject to the approval of the shareholders meeting, except for an interim dividend which may be considered and approved from time to time upon the Board
Fiscal End31 Dec 2026
The person supervising accountingMr. Khanin Trakulveerasak (Start Date 19 Oct 2022)
The person taking the highest responsibility in finance and accountingMr. Sukhum Phothisawadee (Start Date 1 Nov 2021)
Capital Detail
Common Stock
Authorized Capital350,000,000
Paid-up Capital350,000,000
Preferred Shares
Authorized Capital-
Paid-up Capital-
Shares Detail
Common Stock
Listed Shares700,000,000
Paid-up Stock700,000,000Voting Right Ratio 1:1
Treasury Stock - : - - : -
Voting Stock minus Treasury Stock 31 Mar 2026 : 700,000,000 10 Apr 2026 : 700,000,000
Preferred Shares
Listed Shares-
Paid-up Stock-Voting Right Ratio -
Treasury Stock - : - - : -
Voting Stock minus Treasury Stock - : - - : -

Key Issues

Upcoming Event

Relate Stock Sectors

Check out other big names from the same Sectors NAM

symbol-https://s3.efinancethai.com/symbols-logo/NAM.pngNAM
efin Focus Metrics
Quarter 4/2025
Z-Score
3.05
4.13
2.96
Monitor C-Score
0.00
0.00
0.00
ICR
7.39
-206.99
9.74
DSCR
0.00
-0.94
1.43
EV/EBITDA
244,243.95
7.93
11.14
FCF Yield
0.00
0.00
16.66
FCF/Net Income
0.00
0.00
3.38
Net Debt/EBITDA
0.00
0.52
0.33
ROIC
9.35
36.79
6.69
Valuation Metrics
Last Price
3.80
4.64
4.08
P/E
24.12
7.83
22.75
P/BV
1.22
2.46
1.35
Dividend Yield
4.29
8.79
0.00
Financial Strength
D/E
0.45
0.89
0.41
Current Ratio
2.94
2.13
1.73
Net Profit Margin
6.44
15.16
6.15
ROE/ROA
0.83
1.56
1.00
Growth Metrics
Revenue Growth YoY
21.66
-19.19
7.56
Revenue Growth 3Y
0.00
81.11
29.04
Revenue Growth 3Y CAGR
0.00
21.89
8.87
Revenue per Share
0.00
0.00
0.00
EPS Growth
-45.62
-29.75
78.47
EBITDA Growth
-10.76
31.68
66.94
5Y CAGR Total Return
0.00
18.86
-19.07
Market Cap (M.Bath)
2,450.00
2,390.93
2,784.58
Average Volume
335.07
4,792.05
3,249.85

efin Focus Metrics

Quarter 4/2025
Z-Score
Monitor C-Score
ICR
DSCR
EV/EBITDA
FCF Yield
FCF/Net Income
Net Debt/EBITDA
ROIC
Z-Score
xxx
xxx
xxx
Monitor C-Score
xxx
xxx
xxx
ICR
xxx
xxx
xxx
DSCR
xxx
xxx
xxx
EV/EBITDA
xxx
xxx
xxx
FCF Yield
xxx
xxx
xxx
FCF/Net Income
xxx
xxx
xxx
Net Debt/EBITDA
xxx
xxx
xxx
ROIC
xxx
xxx
xxx

Valuation Metrics

Last Price
3.80
4.64
4.08
P/E
24.12
7.83
22.75
P/BV
1.22
2.46
1.35
Dividend Yield
4.29
8.79
0.00

Financial Strength

D/E
0.45
0.89
0.41
Current Ratio
2.94
2.13
1.73
Net Profit Margin
6.44
15.16
6.15
ROE/ROA
0.83
1.56
1.00

Growth Metrics

Revenue Growth YoY
21.66
-19.19
7.56
Revenue Growth 3Y
0.00
81.11
29.04
Revenue Growth 3Y CAGR
0.00
21.89
8.87
Revenue per Share
0.00
0.00
0.00
EPS Growth
-45.62
-29.75
78.47
EBITDA Growth
-10.76
31.68
66.94
5Y CAGR Total Return
0.00
18.86
-19.07
Market Cap (M.Bath)
2,450.00
2,390.93
2,784.58
Average Volume
335.07
4,792.05
3,249.85
Note
  • Calculated using adjusted prices.
  • Data is shown and calculated based on consolidated financial statements, presented as year-to-date quarterly figures. (If consolidated statements are unavailable, company-only statements are used.)
  • Financial data is updated quarterly within 7 business days after new statements are released.
  • Financial statement data reflects what listed companies submit for each period. Users should review the full financial statements for details, as some companies may revise comparative figures in the latest full version.
  • The list of companies included in the SETESG Index is announced together with other indices, based on the latest SET ESG Ratings results. Source: www.set.or.th (Copyright @ The Stock Exchange of Thailand).